Gujarat Themis Biosyn Profit & Loss Annual

BSE: 506879 | NSE: - | ISIN: INE942C01045 | Sector: Biotechnology & Drugs

326.00 +14.05 (4.50%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	169.82	148.97	114.85	90.56
Total Revenue	169.82	148.97	114.85	90.56
Costof Revenue Total	68.14	57.19	16.62	15.37
Gross Profit	101.68	91.79	98.24	75.19
Selling/ General/ Admin Expenses Total	10.21	9.29	7.08	7.11
Depreciation/ Amortization	3.54	2.58	2.23	1.73
Other Operating Expenses Total	12.74	5.34	33.11	27.75
Total Operating Expense	94.62	77.33	59.04	51.97
Operating Income	75.20	71.64	55.81	38.60
Interest Inc( Exp) Net- Non- Op Total	-2.29	43.06	-6.88	-5.49
Other Net	4.37	1.52	3.91	2.83
Net Income Before Taxes	79.33	77.46	59.03	40.88
Provisionfor Income Taxes	20.17	19.50	15.41	10.70
Net Income After Taxes	59.16	57.97	43.62	30.18
Net Income Before Extra Items	59.16	57.97	43.62	30.18
Net Income	59.16	57.97	43.62	30.18
Income Availableto Com Excl Extra Ord	59.16	57.97	43.62	30.18
Income Availableto Com Incl Extra Ord	59.16	57.97	43.62	30.18
Diluted Net Income	59.16	57.97	43.62	30.18
Diluted Weighted Average Shares	7.27	7.26	7.26	7.26
Diluted EPS Excluding Extra Ord Items	8.14	7.98	6.01	4.15
DPS- Common Stock Primary Issue	1.00	1.08	2.20	-
Diluted Normalized EPS	8.14	7.98	6.01	4.15
Research Development	-	29.32	-	-
Total Adjustmentsto Net Income	-	-	-	0.00